Advertisement
Journal Home
Search for

Issue

Alert me when new journal issues are available via Request TOC Alert via emailor via Request RSS feed of current issue

previous issue next issue

Seminars in Oncology
Volume 33, Supplement 3, Pages 1-36 (February 2006)
Search Within This Issue
Past, Present, and Future Developoments in CTCL
Edited by Francine Foss, Sean Whittaker
Zeneus Pharma

display abstract citation download email a colleague
Display:

free full text =free full text


Masthead free full text
page CO2
Full-Text PDF (39 KB)


Introduction free full text
Francine Foss, Sean Whittaker
pages 1-2
Full Text | Full-Text PDF (57 KB)


Biological Insights into the Pathogenesis of Cutaneous T-Cell Lymphomas (CTCL)
Sean Whittaker
pages 3-6
Abstract | Full Text | Full-Text PDF (318 KB)


Therapeutic Advances in Cutaneous T-Cell Lymphoma (CTCL): From Retinoids to Rexinoids
Rudolf Stadler, Almut Kremer
pages 7-10
Abstract | Full Text | Full-Text PDF (206 KB)


Clinical Experience With Denileukin Diftitox (ONTAK)
Francine Foss
pages 11-16
Abstract | Full Text | Full-Text PDF (322 KB)


Combination Treatment Modalities in Cutaneous T-Cell Lymphoma (CTCL)
Joan Guitart
pages 17-20
Abstract | Full Text | Full-Text PDF (88 KB)


Immunomodulatory Effects of Rexinoids
Francine Foss
pages 21-25
Abstract | Full Text | Full-Text PDF (175 KB)


Clinical Experience: Practical Management of Five Patients With Cutaneous T-Cell Lymphoma (CTCL)-Related Symptoms
Reinhard Dummer, Francine Foss, Brigitte Dreno, Martine Bagot
pages 26-32
Abstract | Full Text | Full-Text PDF (309 KB)


Future Perspectives in the Treatment of Cutaneous T-Cell Lymphoma (CTCL)
Reinhard Dummer
pages 33-36
Abstract | Full Text | Full-Text PDF (172 KB)

Frontmatter


Contents free full text
page A1
Full-Text PDF (31 KB)

display abstract citation download email a colleague
Display:
Advertisement